Panacea Biotec increases availability of life saving drug Cilamin 250

The New Delhi based biotech firm, Panacea Biotec has said that it has increased the supply of the life saving drug, Cilamin250 that had witnessed shortage in the market

Representational Image.

New Delhi: Panacea Biotec announced that it has increased the availability of Life Saving Drug Cilamin 250 (D-Penicillamine IP 250 mg) capsules used for treatment of Wilson’s disease, Rheumatoid Arthritis and other conditions. These capsules witnessed short supply in the market during last few months due to non-availability of raw material i.e. D-Penicillamine, in India.